title: Vascular access and contrast media.
abstract: Over the past several years, the Food and Drug Administration (FDA) has received more than 250 adverse event reports in which vascular access devices have ruptured when used with power injectors. The adverse events include rupture and device fragmentation. The outcome of these events affects both the patient and the care provider.
authors.affiliation: Banner Health, Banner Good Samaritan Medical Center, Phoenix, Arizona, USA. ann.earhart@bannerhealth.com
authors.forename: Ann
authors.initials: A
authors.lastname: Earhart
authors.forename: Paula
authors.initials: P
authors.lastname: McMahon
mesh_terms: D002405:Catheterization, Central Venous / Q000295:instrumentation / Q000379:methods*; D002408:Catheters, Indwelling; D003287:Contrast Media; D005119:Extravasation of Diagnostic and Therapeutic Materials; D005682:Gadolinium; D006801:Humans; D007262:Infusions, Intravenous / Q000295:instrumentation / Q000379:methods*; D009994:Osmolar Concentration; D014481:United States; D014486:United States Food and Drug Administration; D014783:Viscosity
chemical_list: D003287:Contrast Media; D005682:Gadolinium